In a recent study, researchers combined clinical and laboratory studies to show the PPM1D gene can confer blood cells exposed to the chemotherapy agent cisplatin a survival advantage that might favor the development of leukemia years later.
Trick-or-treating, dressing up in costume and having fun are all most children want to do on Halloween, but for some divorced families it can be a challenge to figure out how to make the night a treat and not a fright.
A team of physician-scientists at Baylor College of Medicine and Texas Children’s Hospital are now using a new treatment option for pediatric patients with liver tumors, called Transarterial Radioembolization (TARE).
Dr. Hsiao-Tuan Chao, instructor of pediatrics at Baylor College of Medicine, has been awarded the NIH's High-Risk, High-Reward grant, which recognizes highly innovative research to address major challenges in biomedical research.
To better understand a predisposition for acute lymphoblastic leukemia in children with Down syndrome, a team of researchers will sequence the genomes of more than 2,000 individuals with Down syndrome.
In a review published in New England Journal of Medicine, physician-scientists review the history of Langerhans-cell histiocytosis (LCH) and the recent developments that will help propel the treatment for patients into the realm of personalized medicine.